www.bloomberg.com
Humana and Mark Cuban are exploring a pharmacy partnership, potentially disrupting the pharmacy benefit manager (PBM) landscape. This collaboration, confirmed by both Cuban and Humana’s CEO, aims to challenge established PBMs by offering potentially lower drug prices or a more transparent pricing model. The partnership’s specifics remain undisclosed, but its ambition is to exert pressure on existing industry giants in the pharmacy middleman sector. This move signals a growing trend of companies seeking to bypass traditional PBMs to control drug costs.
